Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
322 participants
OBSERVATIONAL
2022-03-01
2029-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• Is there an elicitor specific difference in the occurrence of anaphylactic reactions once the elicitor has been identified and the patient received counselling about its avoidance?
Participants will answer questionnaires via a link they will receive via e-mail at baseline and 3, 6, 12 and 24 months after inclusion in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reactive Doses and Times During Oral Food Challenge to Peanut
NCT03852342
Integrated Approaches to Food Allergen and Allergy Risk Management
NCT02295397
Relevance of Sensitization to Legumes in Children Allergic to Peanut
NCT04329078
Early Peanut Introduction: Translation to Clinical Practice
NCT03019328
Accidental Reactions in Peanut/Tree Nut Allergic Children
NCT05671471
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is intended to help improve the care for future patients in order to minimize the risk of repeat reactions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Food Anaphylaxis Patients
Patients with anaphylaxis to legumes, tree nuts, seeds, cereals and pseudocereals within the last 12 months
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* participation in the European Anaphylaxis Registry (Clinical Trials Identifier: NCT05210543)
* possibility and consent to receive links to the follow-up electronic surveys via e-mail and fill out the questionnaires electronically
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Margitta Worm
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Margitta Worm, MD
Role: PRINCIPAL_INVESTIGATOR
Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charité Universitätsmedizin Berlin
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EA2/137/21
Identifier Type: OTHER
Identifier Source: secondary_id
EPAP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.